Long-term dynamics of multiple sclerosis iron rim lesions / Claudia E. Weber, Matthias Wittayer, Matthias Kraemer, Andreas Dabringhaus, Kathrin Bail, Michael Platten, Lucas Schirmer, Achim Gass, Philipp Eisele
BACKGROUND: Several studies have pointed out that seemingly chronic multiple sclerosis (MS) lesions may also be in inflammatory states. In pathological studies, up to 40% of chronic MS lesions are characterized as "chronic active" or "smoldering" lesions that are characterized by a rim of iron-laden proinflammatory macrophages/microglial cells at the lesion edge with low-grade continuous myelin breakdown. In vivo, these lesions can be visualized as "iron rim lesions" (IRLs) on susceptibility-weighted imaging (SWI). The aim of this study was to investigate the long-term dynamics of IRLs in vivo for a more detailed evolution of dynamic lesion volume changes occurring over time. - METHODS: We retrospectively identified patients with MS who were followed for at least 36 months (up to 72 months) and underwent at least an annual MRI on the same 3 Tsystem. Using Voxel-Guided Morphometry (VGM) we investigated regional volume changes within lesions and correlated these findings with SWI for the presence of a characteristic hypointense lesion rim. To estimate tissue damage, apparent diffusion coefficient (ADC) values for every lesion at baseline and follow-up MRIs were determined. - RESULTS: Forty-three patients were included in the study. Overall, we identified 302 supratentorial non-confluent MS lesions (52 persistent IRLs, nine transient IRLs, 228 non-IRLs and 13 acute contrast-enhancing lesions). During follow-up, persistent IRLs significantly enlarged, whereas non-IRLs showed a tendency to shrink. At baseline MRI, ADC values were significantly higher in persistent IRLs (1.23 × 10-3 mm/s2) compared to non-IRLs (1.01 × 10-3 mm/s2; p < 0.001), but not compared to transient IRLs (1.06 × 10-3 mm/s2; p = 0.15) and contrast-enhancing lesions (1.15 × 10-3 mm/s2; p = 1.0). During follow-up, ADC values significantly increased more often in persistent IRLs compared to all other lesion types (p < 0.0001). - CONCLUSIONS: Our long-term data demonstrate that persistent IRLs enlarge during disease duration, whereas non-IRLs show a tendency to shrink. Furthermore, IRLs are associated with sustained tissue damage, supporting the notion that IRLs could represent a new imaging biomarker in MS..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
---|---|
Enthalten in: |
Multiple Sclerosis and Related Disorders - 57(2022), Artikel-ID 103340, Seite 1-10 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Weber, Claudia Ellen, 1986- [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Brain |
---|
Anmerkungen: |
Available online 18 October 2021 Gesehen am 02.09.2022 |
---|
Umfang: |
10 |
---|
doi: |
10.1016/j.msard.2021.103340 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1815707593 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1815707593 | ||
003 | DE-627 | ||
005 | 20240417193350.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220902s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.msard.2021.103340 |2 doi | |
035 | |a (DE-627)1815707593 | ||
035 | |a (DE-599)KXP1815707593 | ||
035 | |a (OCoLC)1361696633 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Weber, Claudia Ellen |d 1986- |e verfasserin |0 (DE-588)1031228764 |0 (DE-627)736021477 |0 (DE-576)378667955 |4 aut | |
245 | 1 | 0 | |a Long-term dynamics of multiple sclerosis iron rim lesions |c Claudia E. Weber, Matthias Wittayer, Matthias Kraemer, Andreas Dabringhaus, Kathrin Bail, Michael Platten, Lucas Schirmer, Achim Gass, Philipp Eisele |
264 | 1 | |c 2022 | |
300 | |a 10 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Available online 18 October 2021 | ||
500 | |a Gesehen am 02.09.2022 | ||
520 | |a BACKGROUND: Several studies have pointed out that seemingly chronic multiple sclerosis (MS) lesions may also be in inflammatory states. In pathological studies, up to 40% of chronic MS lesions are characterized as "chronic active" or "smoldering" lesions that are characterized by a rim of iron-laden proinflammatory macrophages/microglial cells at the lesion edge with low-grade continuous myelin breakdown. In vivo, these lesions can be visualized as "iron rim lesions" (IRLs) on susceptibility-weighted imaging (SWI). The aim of this study was to investigate the long-term dynamics of IRLs in vivo for a more detailed evolution of dynamic lesion volume changes occurring over time. - METHODS: We retrospectively identified patients with MS who were followed for at least 36 months (up to 72 months) and underwent at least an annual MRI on the same 3 Tsystem. Using Voxel-Guided Morphometry (VGM) we investigated regional volume changes within lesions and correlated these findings with SWI for the presence of a characteristic hypointense lesion rim. To estimate tissue damage, apparent diffusion coefficient (ADC) values for every lesion at baseline and follow-up MRIs were determined. - RESULTS: Forty-three patients were included in the study. Overall, we identified 302 supratentorial non-confluent MS lesions (52 persistent IRLs, nine transient IRLs, 228 non-IRLs and 13 acute contrast-enhancing lesions). During follow-up, persistent IRLs significantly enlarged, whereas non-IRLs showed a tendency to shrink. At baseline MRI, ADC values were significantly higher in persistent IRLs (1.23 × 10-3 mm/s2) compared to non-IRLs (1.01 × 10-3 mm/s2; p < 0.001), but not compared to transient IRLs (1.06 × 10-3 mm/s2; p = 0.15) and contrast-enhancing lesions (1.15 × 10-3 mm/s2; p = 1.0). During follow-up, ADC values significantly increased more often in persistent IRLs compared to all other lesion types (p < 0.0001). - CONCLUSIONS: Our long-term data demonstrate that persistent IRLs enlarge during disease duration, whereas non-IRLs show a tendency to shrink. Furthermore, IRLs are associated with sustained tissue damage, supporting the notion that IRLs could represent a new imaging biomarker in MS. | ||
650 | 4 | |a Brain | |
650 | 4 | |a Chronic active lesions | |
650 | 4 | |a Humans | |
650 | 4 | |a Iron | |
650 | 4 | |a Iron rim lesions | |
650 | 4 | |a Magnetic Resonance Imaging | |
650 | 4 | |a MRI | |
650 | 4 | |a Multiple sclerosis | |
650 | 4 | |a Multiple Sclerosis | |
650 | 4 | |a Retrospective Studies | |
650 | 4 | |a SWI | |
700 | 1 | |a Wittayer, Matthias Sebastian |d 1988- |e verfasserin |0 (DE-588)1191137686 |0 (DE-627)166958853X |4 aut | |
700 | 1 | |a Kraemer, Matthias |e verfasserin |4 aut | |
700 | 1 | |a Dabringhaus, Andreas |e verfasserin |4 aut | |
700 | 1 | |a Bail, Kathrin |d 1992- |e verfasserin |0 (DE-588)1221644319 |0 (DE-627)1738959341 |4 aut | |
700 | 1 | |a Platten, Michael |d 1971- |e verfasserin |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
700 | 1 | |a Schirmer, Lucas |d 1981- |e verfasserin |0 (DE-588)140880631 |0 (DE-627)70381737X |0 (DE-576)321212088 |4 aut | |
700 | 1 | |a Gass, Achim |d 1961- |e verfasserin |0 (DE-588)1025167171 |0 (DE-627)721356001 |0 (DE-576)370026632 |4 aut | |
700 | 1 | |a Eisele, Philipp |d 1982- |e verfasserin |0 (DE-588)140579834 |0 (DE-627)619812486 |0 (DE-576)31895656X |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Multiple Sclerosis and Related Disorders |d Amsterdam [u.a.] : Elsevier, 2012 |g 57(2022), Artikel-ID 103340, Seite 1-10 |h Online-Ressource |w (DE-627)683365622 |w (DE-600)2645330-7 |w (DE-576)357960025 |x 2211-0356 |7 nnns |
773 | 1 | 8 | |g volume:57 |g year:2022 |g elocationid:103340 |g pages:1-10 |g extent:10 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.msard.2021.103340 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_90 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_370 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4313 | ||
951 | |a AR | ||
952 | |d 57 |j 2022 |i 103340 |h 1-10 |g 10 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 4184361811 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 02-09-22 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2022 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_9 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_10 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1448668417 |a Weber, Claudia Ellen | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1773576402 |a Wittayer, Matthias Sebastian | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_2 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)173895997X |a Bail, Kathrin | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_5 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s p |0 (DE-627)1450189547 |a Platten, Michael | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |a pos_6 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s p |0 (DE-627)1684099900 |a Schirmer, Lucas | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |a pos_7 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s p |0 (DE-627)1440037728 |a Gass, Achim | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 09 |s s |a pos_8 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s p |0 (DE-627)1445500493 |a Eisele, Philipp | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s k |0 (DE-627)1416468684 |a Neurologische Klinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 10 |s s |a pos_9 |